Dear colleagues, esteemed participants of the MUNICH VASCULAR CONFERENCE (MAC),

It is with great honor and pleasure that I extend this heartfelt invitation to you for the upcoming 13th MUNICH VASCULAR CONFERENCE (MAC), scheduled to take place exclusively as a face-to-face symposium on December 5 – 6, 2024 at the University Hospital of the Technical University of Munich (TUM). Building upon the legacy of its predecessors, this esteemed gathering has become a tradition in the field of vascular medicine, fostering valuable exchanges between clinicians and colleagues from translational and basic vascular research.

I am humbled to assume the responsibility of organizing this conference, succeeding the late Prof. Dr. Hans-Henning Eckstein, who, sadly, passed away earlier this year. Professor Eckstein played a pivotal role in shaping the success of the previous conferences, and I am committed to upholding his legacy by elevating the 13th MAC to new heights.

The MAC has always been a platform for robust discussions, and I am proud to inform you that the tradition continues.
The symposium will cover a comprehensive spectrum of vascular diseases, providing an opportunity for clinicians and researchers to mutually benefit from the wealth of knowledge shared. The scientific faculty for the 13th MAC will be composed of world-class speakers and key opinion leaders in the field of arterial and venous diseases, as well as experts in artificial intelligence and digital vascular medicine. Our focus will encompass critical aspects of endovascular, open surgical, and the best medical treatment options for vascular patients.

I invite you to explore our website, where you will find detailed information about the exciting topics that will be addressed during the conference. The 13th MAC aims to continue the legacy of its predecessors in delivering outstanding presentations from a distinguished faculty.

I am eagerly anticipating the opportunity to welcome you personally to Munich in December 2024. Munich, especially in the weeks leading up to Christmas, offers a delightful setting for intellectual exchange and camaraderie. Consider extending your stay to enjoy the festive atmosphere with your partners or family.

For more updates and detailed information, please visit

I look forward to your participation and the continued success of the MUNICH VASCULAR CONFERENCE.


Univ.-Prof. Dr. Dr. med. Daniela Branzan
The Organizing Committee, 13th MUNICH VASCULAR CONFERENCE (MAC).


The MAC is organized in close cooperation with
wikonect GmbH /Wiesbaden/Germany.

General Information

Scientific Director

Univ.-Prof. Dr. Dr. med. Daniela Branzan
Head of the Clinic for Vascular and Endovascular Surgery, TUM School of Medicine and Health, Technical University of Munich, Germany

Congress Secretariat

Michael Kallmayer
Christoph Knappich
Katharina Funk
Eva Knipfer
Johanna Müller

Event type

On-site conference


At the last face-to-face meeting 2019 we experienced a record participation of more than 600 attendees. In 2021 we could attract far more than 1.000 online-participants from 71 countries. In 2022 the event was also held as digital conference with 620 participants. Fortunately
the conference could again be a hybrid meeting in 2023. There we welcomed 350 attendees on-site and 200 participants online.

Target group

Vascular clinicans from all vascular medical specialities and colleagues from translational and basic research.

Official conference language


Congress Organizer

wikonect GmbH | Wiesbaden | Germany
+49 611 204809-0 |

Main Topics


• New imaging modalities for diagnostic, treatment and follow-up of patients with PAD
• Antithrombotic and anticoagulation management of PAD
• Endovascular and surgical treatment options for PAD
• Claudication: what is appropriate treatment?
• Multidisciplinary management of chronic limb-threatening ischemia


• Update of modern conservative management for carotid lesions
• Asymptomatic carotid stenosis – screening and multimodal treatment
• Clinical and therapeutic advances for carotid-related stroke and symptomatic carotid disease
• Surgical and endovascular revascularization options of carotid lesions


• Management of abdominal, thoracic and thoraco-abdominal aortic aneurysms
• Patient-tailored approach for diagnostics and treatment of complex aortic aneurysm
• Solutions for acute and chronic aortic dissections
• Advances in functional aortic imaging
• Management of Aortic graft infections


• Diagnosis and treatment (surgical vs. endovenous techniques) of superficial varicosis
• Pelvic congestion syndrome
• Acute deep venous thrombosis – recanalization and/or anticoagulation
• Diagnosis and treatment of chronic venous obstructions
• Approaches to venous thoracic outlet syndrome
• Advances in the treatment of venous ulcers


• Planning and navigation tools for hybrid operating rooms
• 3D Printing in vascular medicine
• Robotics in vascular surgery
• Mixed and augmented reality
• Artificial intelligence for vascular specialists


• Genetics, genomics, and proteomics in atherosclerosis research
• Modulation of cardiovascular diseases by the gut microbiota
• Translational vascular medicine: from molecules to therapies
• Translational photoacoustics in vascular diagnostics


• New open and endovascular procedures for vascular access
• New materials for prosthetic shunts
• Intervention vs. primary surgical revision for dysfunctional vascular access


• Sustainability in vascular medicine
• Vascular anomalies
• Visceral and renal vascular disorders




• Practical courses for Duplex ultrasound (carotid, peripheral vessels, aorta)
• Practical courses for open and endovascular surgery
• Radiation protection course


Ethical MedTech | Trusted Partner